Coronavirus Disease 2019
Conditions
Brief summary
As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.
Interventions
The investigators retrospectively analyzed the hospitalized patients with COVID-19.
Sponsors
Huizhou Municipal Central Hospital
Guangzhou Institute of Respiratory Disease
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
* Hospitalized patients with COVID19
Exclusion criteria
* Suspected patients with COVID19, not confirmed by the laboratory * Patients who are refused to receive medical treatments
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Time to negative conversion of severe acute respiratory syndrome coronavirus 2 | 1 month | The primary outcome is the time to negative conversion of coronavirus |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Length of stay in hospital | 1 month | The time of hospitalization. |
| Survival | 1 month | The rate of survival within hospitalization of these patients will be tracked. |
| Intubation | 1 month | The rate of intubation within hospitalization of these patients will be tracked. |
Countries
China
Outcome results
None listed